Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Product Approvals
|
Clinical Trials
|
Product Filings
|
Product Safety
|
Preclinical
|
Product Delays
|
Positive top-line Phase IIb for Lipid Therapeutics' ulcerative colitis drug
23 June 2011
Pial Ganguli
Please Login to read the full article.
Not a subscriber?
Subscribe to Scrip
Request a FREE Trial
RELATED CONTENT
NEWS
Scrip News
Positive Phase III data for LifeCycle's 'improved Prograf' despite higher drop-out
US FDA panel backs Remicade use for ulcerative colitis in children
Furiex ready to progress MuDelta for IBS to Phase III
Shire's ulcerative colitis drug gains expanded indication in US
Other Informa News
Edwards' Sapien TAVI device closer to US approval with positive FDA report
GE Healthcare warns UK MPs: We lose focus on early diagnosis at our peril
COMMENT
Scrip Comment
J&J stent exit – another missed opportunity
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads